Trademarkia Logo

Australia

AU$
REZFORZIN
Cancelled: Cancelled at the request of IB

Last updated on 25 Jun 2024

Owner Info

Cidara Therapeutics, Inc.

6310 NANCY RIDGE DR.

SAN DIEGO CA 92121, UNITED STATES OF AMERICA

Serial Number

2147063 filed on 30 Nov 2020

Correspondent

Nadine H. Jacobson

151 W 42nd St, 17th Floor,

New York NY 10036,

UNITED STATES OF AMERICA

REZFORZIN

Classification Information


Class [005]
Pharmaceutical and biological preparations for human use; pharmaceutical and biological preparations to prevent and treat fungal infections and diseas Read More

Mark Details


Serial Number

2147063

Registered On

30 Nov 2020

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

9 Nov 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
25th Jun 2024Status change to Voided
19th Jun 2021International Registration in Australia Protected correspondence sent
18th Jun 2021IP Right Registration Published
18th Jun 2021Status change to Registered/Protected
10th Apr 2021Application Accepted correspondence sent
10th Apr 2021IP Right has been Examined
10th Apr 2021IP Right Acceptance Published
2th Feb 2021Status change to Accepted
6th Jan 2021Awaiting examination
6th Jan 2021Examination expedited